Developmental Activities. 3.1 While this Agreement is in effect, DOV shall use reasonable efforts to develop and commercialize the Product, either through itself or through a third party commercial partner. Such activities include negotiating the terms of a sublicense agreement with a third party. 3.2 DOV may disclose unpublished Wyeth Patents and Wyeth Know-How to a third party, bound under an obligation of confidentiality which is substantially the same as the obligation provided for in Article 7 of this License Agreement, to the extent necessary to negotiate a sublicense, and thereafter to develop and commercialize the Product. 3.3 On a quarterly basis, DOV shall provide Wyeth with a written report outlining its developmental activities during that quarter.
Appears in 2 contracts
Sources: Assignment and License Agreement (Neurocrine Biosciences Inc), License Agreement (Neurocrine Biosciences Inc)
Developmental Activities. 3.1 While this Agreement is in effect, DOV shall use reasonable efforts to develop and commercialize the Product, either through itself or through a third party commercial partner. Such activities include negotiating the terms of a sublicense agreement with a third party.
3.2 DOV may disclose unpublished Wyeth ACY Patents and Wyeth ACY Know-How to a third party, bound under an obligation of confidentiality which is substantially the same as the obligation provided for in Article 7 of this License Agreement, to the extent necessary to negotiate a sublicense, and thereafter to develop and commercialize the Product.
3.3 On a quarterly basis, DOV shall provide Wyeth ACY with a written report outlining its developmental activities during that quarter.
Appears in 1 contract